Shaji K Kumar, MD &ndash; Research Output

2019

Fludeoxyglucose F 18 PET/Computed Tomography Evaluation of Therapeutic Response in Multiple Myeloma

Kumar, S. K., Glazebrook, K. N. & Broski, S., Jan 1 2019, In : PET Clinics.

Research output: Contribution to journal › Review article

Fluorodeoxyglucose F18

Multiple Myeloma

tomography

Bone Marrow

Tomography

1 Citation (Scopus)

International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders

Hillengass, J., Usmani, S., Rajkumar, S. V., Durie, B. G. M., Mateos, M. V., Lonial, S., Joao, C., Anderson, K. C., García-Sanz, R., Serra, E. R., Du, J., van de Donk, N., Berdeja, J. G., Terpos, E., Zamagni, E., Kyle, R. A., San Miguel, J., Goldschmidt, H., Giralt, S., Kumar, S. K. & 15 others, Raje, N., Ludwig, H., Ocio, E., Schots, R., Einsele, H., Schjesvold, F., Chen, W. M., Abildgaard, N., Lipe, B. C., Dytfeld, D., Wirk, B. M., Drake, M. M., Cavo, M., Lahuerta, J. J. & Lentzsch, S., Jun 1 2019, In : The Lancet Oncology. 20, 6, p. e302-e312

Research output: Contribution to journal › Review article

Plasma Cells

Multiple Myeloma

Therapeutics

Bone Marrow

Bone and Bones

5 Citations (Scopus)

Pros and cons of frontline autologous transplant in multiple myeloma: The debate over timing

Kumar, S. K., Buadi, F. K. & Rajkumar, S. V., Feb 14 2019, In : Blood. 133, 7, p. 652-659 8 p.

Research output: Contribution to journal › Review article

Autografts

Stem Cell Transplantation

Stem cells

Multiple Myeloma

Therapeutics

1 Citation (Scopus)

Targeted management strategies in multiple myeloma

Kumar, S. K., Jan 1 2019, In : Cancer Journal (United States). 25, 1, p. 59-64 6 p.

Research output: Contribution to journal › Review article

Multiple Myeloma

Clonal Evolution

Therapeutics

Drug Combinations

Treatment Failure

4 Citations (Scopus)

Treatment of multiple myeloma: ASCO and CCO joint clinical practice guideline

Mikhael, J. R., Ismaila, N., Cheung, M. C., Costello, C., Dhodapkar, M. V., Kumar, S. K., Lacy, M., Lipe, B., Little, R. F., Nikonova, A., Omel, J., Peswani, N., Prica, A., Raje, N., Seth, R., Vesole, D. H., Walker, I., Whitley, A., Wildes, T. M., Wong, S. W. & 1 others, Martin, T., Jan 1 2019, In : Journal of Clinical Oncology. 37, 14, p. 1228-1263 36 p.

Research output: Contribution to journal › Review article

Multiple Myeloma

Practice Guidelines

Joints

Guidelines

Radiation Oncology

2018

4 Citations (Scopus)

Interpreting clinical trial data in multiple myeloma: translating findings to the real-world setting

Richardson, P. G., San Miguel, J. F., Moreau, P., Hajek, R., Dimopoulos, M. A., Laubach, J. P., Palumbo, A., Luptakova, K., Romanus, D., Skacel, T., Kumar, S. K. & Anderson, K. C., Nov 1 2018, In : Blood Cancer Journal. 8, 11, 109.

Research output: Contribution to journal › Review article

Multiple Myeloma

Clinical Trials

Therapeutics

Controlled Clinical Trials

Costs and Cost Analysis

37 Citations (Scopus)

Management of relapsed and refractory multiple myeloma: Novel agents, antibodies, immunotherapies and beyond

Chim, C. S., Kumar, S. K., Orlowski, R. Z., Cook, G., Richardson, P. G., Gertz, M., Giralt, S., Mateos, M. V., Leleu, X. & Anderson, K. C., Feb 1 2018, In : Leukemia. 32, 2, p. 252-262 11 p.

Research output: Contribution to journal › Review article

Multiple Myeloma

Immunotherapy

Antibodies

Dexamethasone

Disease-Free Survival

30 Citations (Scopus)

Multiple Myeloma, version 3.2018: Featured updates to the NCCN guidelines

Kumar, S. K., Callander, N. S., Alsina, M., Atanackovic, D., Biermann, J. S., Castillo, J., Chandler, J. C., Costello, C., Faiman, M., Fung, H. C., Godby, K., Hofmeister, C., Holmberg, L., Holstein, S., Huff, C. A., Kang, Y., Kassim, A., Liedtke, M., Malek, E., Martin, T. & 10 others, Neppalli, V. T., Omel, J., Raje, N., Singhal, S., Somlo, G., Stockerl-Goldstein, K., Weber, D., Yahalom, J., Kumar, R. & Shead, D. A., Jan 1 2018, In : JNCCN Journal of the National Comprehensive Cancer Network. 16, 1, p. 11-20 10 p.

Research output: Contribution to journal › Review article

Multiple Myeloma

Guidelines

Aftercare

Therapeutics

2017

9 Citations (Scopus)

New developments in the management of relapsed/refractory multiple myeloma – The role of ixazomib

Richardson, P. G., Kumar, S. K., Laubach, J. P., Paba-Prada, C., Gupta, N., Berg, D., van de Velde, H. & Moreau, P., Aug 22 2017, In : Journal of Blood Medicine. 8, p. 107-121 15 p.

Research output: Contribution to journal › Review article

Multiple Myeloma

Quality of Life

Proteasome Inhibitors

Therapeutics

Patient Safety

92 Citations (Scopus)

Role of ¹⁸F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group

Cavo, M., Terpos, E., Nanni, C., Moreau, P., Lentzsch, S., Zweegman, S., Hillengass, J., Engelhardt, M., Usmani, S. Z., Vesole, D. H., San-Miguel, J., Kumar, S. K., Richardson, P. G., Mikhael, J. R., da Costa, F. L., Dimopoulos, M. A., Zingaretti, C., Abildgaard, N., Goldschmidt, H., Orlowski, R. Z. & 8 others, Chng, W. J., Einsele, H., Lonial, S., Barlogie, B., Anderson, K. C., Rajkumar, S. V., Durie, B. G. M. & Zamagni, E., Apr 1 2017, In : The Lancet Oncology. 18, 4, p. e206-e217

Research output: Contribution to journal › Review article

Fluorodeoxyglucose F18

Plasma Cells

Multiple Myeloma

Plasmacytoma

Residual Neoplasm

38 Citations (Scopus)

Therapy for Relapsed Multiple Myeloma: Guidelines From the Mayo Stratification for Myeloma and Risk-Adapted Therapy

Dingli, D. M., Ailawadhi, S., Bergsagel, P. L., Buadi, F. K., Dispenzieri, A., Fonseca, R., Gertz, M., Gonsalves, W., Hayman, S. R., Kapoor, P., Kourelis, T., Kumar, S. K., Kyle, R. A., Lacy, M., Leung, N., Lin, Y., Lust, J. A., Mikhael, J. R., Reeder, C. B., Roy, V. & 7 others, Russell, S. J., Sher, T., Stewart, A. K., Warsame, R., Zeldenrust, S. R., Rajkumar, S. V. & Chanan Khan, A. A., Apr 1 2017, In : Mayo Clinic Proceedings. 92, 4, p. 578-598 21 p.

Research output: Contribution to journal › Review article

Multiple Myeloma

Guidelines

Recurrence

Patient Care

Therapeutics

2016

20 Citations (Scopus)

Clinical use and applications of histone deacetylase inhibitors in multiple myeloma

Tandon, N., Ramakrishna, V. & Kumar, S. K., May 6 2016, In : Clinical Pharmacology: Advances and Applications. 8, p. 35-44 10 p.

Research output: Contribution to journal › Review article

Histone Deacetylase Inhibitors

Multiple Myeloma

Therapeutics

Proteasome Inhibitors

Fatal Outcome

392 Citations (Scopus)

International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

Kumar, S. K., Paiva, B., Anderson, K. C., Durie, B., Landgren, O., Moreau, P., Munshi, N., Lonial, S., Bladé, J., Mateos, M. V., Dimopoulos, M., Kastritis, E., Boccadoro, M., Orlowski, R., Goldschmidt, H., Spencer, A., Hou, J., Chng, W. J., Usmani, S. Z., Zamagni, E. & 20 others, Shimizu, K., Jagannath, S., Johnsen, H. E., Terpos, E., Reiman, A., Kyle, R. A., Sonneveld, P., Richardson, P. G., McCarthy, P., Ludwig, H., Chen, W., Cavo, M., Harousseau, J. L., Lentzsch, S., Hillengass, J., Palumbo, A., Orfao, A., Rajkumar, S. V., Miguel, J. S. & Avet-Loiseau, H., Aug 1 2016, In : The Lancet Oncology. 17, 8, p. e328-e346

Research output: Contribution to journal › Review article

Residual Neoplasm

Multiple Myeloma

Bone Marrow Diseases

Clinical Trials

Bone Marrow Cells

40 Citations (Scopus)

New investigational drugs with single-agent activity in multiple myeloma

Rajan, A. M. & Kumar, S. K., Jul 29 2016, In : Blood Cancer Journal. 6, 7, p. e451

Research output: Contribution to journal › Review article

Investigational Drugs

Multiple Myeloma

Proteasome Inhibitors

Kinesin

Cyclin-Dependent Kinases